Cargando…

TERT Promoter Mutations Are Frequent in Cutaneous Basal Cell Carcinoma and Squamous Cell Carcinoma

Activating mutations in the TERT promoter were recently identified in up to 71% of cutaneous melanoma. Subsequent studies found TERT promoter mutations in a wide array of other major human cancers. TERT promoter mutations lead to increased expression of telomerase, which maintains telomere length an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Griewank, Klaus G., Murali, Rajmohan, Schilling, Bastian, Schimming, Tobias, Möller, Inga, Moll, Iris, Schwamborn, Marion, Sucker, Antje, Zimmer, Lisa, Schadendorf, Dirk, Hillen, Uwe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3832433/ https://www.ncbi.nlm.nih.gov/pubmed/24260374 http://dx.doi.org/10.1371/journal.pone.0080354

Ejemplares similares

Lack of SF3B1 R625 mutations in cutaneous melanoma
por: Schilling, Bastian, et al.
Publicado: (2013)

Targeted massively parallel sequencing of angiosarcomas reveals frequent activation of the mitogen activated protein kinase pathway
por: Murali, Rajmohan, et al.
Publicado: (2015)

Frequent Occurrence of NRAS and BRAF Mutations in Human Acral Naevi
por: Jansen, Philipp, et al.
Publicado: (2019)

Is there a role for immune checkpoint blockade in metastatic uveal melanoma?
por: Schilling, Bastian, et al.
Publicado: (2015)

TERT promoter mutations in ocular melanoma distinguish between conjunctival and uveal tumours
por: Griewank, K G, et al.
Publicado: (2013)

Corticosteroids Augment BRAF Inhibitor Vemurafenib Induced Lymphopenia and Risk of Infection
por: Sondermann, Wiebke, et al.
Publicado: (2015)

Targeted next generation sequencing of mucosal melanomas identifies frequent NF1 and RAS mutations
por: Cosgarea, Ioana, et al.
Publicado: (2017)

Analysis of SDHD promoter mutations in various types of melanoma
por: Scholz, Simone L., et al.
Publicado: (2015)

GNA14, GNA11, and GNAQ Mutations Are Frequent in Benign but Not Malignant Cutaneous Vascular Tumors
por: Jansen, Philipp, et al.
Publicado: (2021)

NF1 mutations in conjunctival melanoma
por: Scholz, S. L., et al.
Publicado: (2018)

Single-strand DNA library preparation improves sequencing of formalin-fixed and paraffin-embedded (FFPE) cancer DNA
por: Stiller, Mathias, et al.
Publicado: (2016)

Genetic and Methylation Analysis of CTNNB1 in Benign and Malignant Melanocytic Lesions
por: Zaremba, Anne, et al.
Publicado: (2022)

Frequent somatic TERT promoter mutations and CTNNB1 mutations in hepatocellular carcinoma
por: Lee, Seung Eun, et al.
Publicado: (2016)

Genetic and Clinical Characteristics of ARID1A Mutated Melanoma Reveal High Tumor Mutational Load without Implications on Patient Survival
por: Thielmann, Carl Maximilian, et al.
Publicado: (2022)

Update in the treatment of non-melanoma skin cancers: the use of PD-1 inhibitors in basal cell carcinoma and cutaneous squamous-cell carcinoma
por: Ascierto, Paolo A, et al.
Publicado: (2022)

A pragmatic approach to carcinomas concurrently involving the endometrium and ovary
por: Murali, Rajmohan, et al.
Publicado: (2018)

Circulating cell‐free messenger RNA enables non‐invasive pan‐tumour monitoring of melanoma therapy independent of the mutational genotype
por: Albrecht, Lea Jessica, et al.
Publicado: (2022)

Macrophages/Microglia Represent the Major Source of Indolamine 2,3-Dioxygenase Expression in Melanoma Metastases of the Brain
por: Herrera-Rios, Dayana, et al.
Publicado: (2020)

Influence of Genetic Variants in Type I Interferon Genes on Melanoma Survival and Therapy
por: Lenci, Romina Elizabeth, et al.
Publicado: (2012)

Ulcerated Metatypical Basal Cell Carcinoma of the Forehead
por: Cardoso, Jose, et al.
Publicado: (2017)

Modulation and Apoptosis of Neutrophil Granulocytes by Extracorporeal Photopheresis in the Treatment of Chronic Graft-Versus-Host Disease
por: Franklin, Cindy, et al.
Publicado: (2015)

The dermatoscopic universe of basal cell carcinoma
por: Lallas, Aimilios, et al.
Publicado: (2014)

The Prognostic Relevance of PMCA4 Expression in Melanoma: Gender Specificity and Implications for Immune Checkpoint Inhibition
por: Hegedüs, Luca, et al.
Publicado: (2022)

Integrated genomic analyses reveal frequent TERT aberrations in acral melanoma
por: Liang, Winnie S., et al.
Publicado: (2017)

Acquired IFNγ resistance impairs anti-tumor immunity and gives rise to T-cell-resistant melanoma lesions
por: Sucker, Antje, et al.
Publicado: (2017)

TERT promoter mutations and gene amplification: Promoting TERT expression in Merkel cell carcinoma
por: Xie, Hong, et al.
Publicado: (2014)

MAL2 and tumor protein D52 (TPD52) are frequently overexpressed in ovarian carcinoma, but differentially associated with histological subtype and patient outcome
por: Byrne, Jennifer A, et al.
Publicado: (2010)

Locally Advanced Basal Cell Carcinoma with Intraocular Invasion
por: Tchernev, Georgi, et al.
Publicado: (2018)

Basal Cell Carcinoma
por: Chung, Seum
Publicado: (2012)

Phase II DeCOG-Study of Ipilimumab in Pretreated and Treatment-Naïve Patients with Metastatic Uveal Melanoma
por: Zimmer, Lisa, et al.
Publicado: (2015)

Metastatic Basal Cell Carcinoma: A Biological Continuum of Basal Cell Carcinoma?
por: Mehta, Karaninder S., et al.
Publicado: (2012)

Basal Cell Carcinoma With Calcification: Case Report of Calcifying Basal Cell Carcinoma and Review of Calcinosis Cutis Associated With Basal Cell Carcinoma
por: Forouzan, Parnia, et al.
Publicado: (2021)

STAT3 Single Nucleotide Polymorphism rs4796793 SNP Does Not Correlate with Response to Adjuvant IFNα Therapy in Stage III Melanoma Patients
por: Schrama, David, et al.
Publicado: (2014)

TERT promoter mutations in renal cell carcinomas and upper tract urothelial carcinomas
por: Wang, Kun, et al.
Publicado: (2014)

Identification of genes involved in the regulation of TERT in hepatocellular carcinoma
por: Amisaki, Masataka, et al.
Publicado: (2019)

Clinical Application of TERT Promoter Mutations in Urothelial Carcinoma
por: Hayashi, Yujiro, et al.
Publicado: (2021)

COMPARISON OF RISK FACTORS OF SINGLE BASAL CELL CARCINOMA WITH MULTIPLE BASAL CELL CARCINOMAS
por: Hallaji, Zahra, et al.
Publicado: (2011)

Is Basal Cell Carcinoma an Itchy Tumor? Clinical Characteristics of Itch in Basal Cell Carcinoma
por: Chlebicka, Iwona, et al.
Publicado: (2020)

Primary Basal Cell Carcinoma Masquerading as Metastatic Basal Cell Carcinoma in the Left Axilla
por: Haskell Hanisch, Brianne, et al.
Publicado: (2023)

TERT Immunohistochemistry Is a Poor Predictor of TERT Promoter Mutations and Gene Expression in Follicular Thyroid Carcinoma
por: Paulsson, Johan O., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_bufe459v7t3g7782djvf7aoi77